MedRx Co., Ltd (TYO:4586)

Japan · Delayed Price · Currency is JPY

89.00

-10.00 (-10.10%)

Sep 18, 2025, 3:30 PM JST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2009 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2009 - 2019
Pharmaceutical Formulation Development and Related Operations	257.92M	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Formulation Development and Related Operations Growth	773.28%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2009 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2009 - 2019
United States	257.59M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	1054.03%	Log In	Log In	Log In	Log In	Upgrade
Japan	325.00K	Log In	Log In	Log In	Log In	Upgrade
Japan Growth	-95.49%	Log In	Log In	Log In	Log In	Upgrade